Supplemental Financial Data (Tables)

9 Months Ended

Sep. 30, 2024

Supplemental Financial Data [Abstract]

Inventories

Inventories

Our inventory consisted of the following (in thousands):

	September 30, 2024		December 31, 2023
Raw materials:
Raw materials - clinical	$	20,773	$	20,985
Raw materials - commercial		963		1,809
Total raw materials		21,736		22,794
Work in process		6,653		5,477
Finished goods		63		154
Total inventories	$	28,452	$	28,425

Accrued Liabilities

Accrued Liabilities

Our accrued liabilities consisted of the following (in thousands):

	September 30, 2024		December 31, 2023
Clinical development expenses	$	90,239	$	105,967
In-licensing expenses		7,082		7,454
Commercial expenses		5,016		4,875
Other miscellaneous expenses		22,059		29,598
Total accrued liabilities	$	124,396	$	147,894